Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trial. - D'Alise AM; Willis J; Duzagac F; Hall MJ; Cruz-Correa M; Idos GE; Thirumurthi S; Ballester V; Leoni G; Garzia I; Antonucci L; De Marco L; et al. (Nature medicine, 2026)